Seres Therapeutics Liabilities 2024

Seres Therapeutics Aktienanalyse

What does Seres Therapeutics do?

Seres Therapeutics Inc is a company specializing in the development of microbiome therapeutics. The company was founded in 2010 by a group of scientists from Harvard University who recognized the potential of the microbiome and were excited by the fact that it has a multitude of impacts on human health. Seres Therapeutics' headquarters are located in Cambridge, Massachusetts, USA. The business model of Seres Therapeutics is based on the research, development, and commercialization of therapeutics based on the microbiome. The microbiome is the collection of all microorganisms, including bacteria, viruses, and fungi, that live in the human body. Seres Therapeutics firmly believes that the microbiome plays a crucial role in maintaining health and aims to develop innovative therapies that can improve the immune system and strengthen the body's defenses based on this. Seres Therapeutics' products are designed for the treatment of gastrointestinal tract diseases, including inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. The company's products harness the potential of the microbiome to improve gut health, particularly by restoring the natural balance of gut flora. In 2016, Seres Therapeutics launched its first approved drug on the market - SER-109, a treatment for recurrent Clostridium difficile infections (CDI). CDI is an infectious disease caused by the bacterium Clostridium difficile and is commonly associated with antibiotic therapies. SER-109 has proven effective in reducing the frequency of CDI infections, making it the first approved microbiome-based therapeutic. Seres Therapeutics is also working on the development of other products. The company has conducted several Phase 2 clinical trials demonstrating the efficacy of its preparations for the treatment of inflammatory bowel disease. Other products in Seres Therapeutics' pipeline are currently being tested for their effectiveness in combating cancer and autoimmune diseases, where the microbiome also plays an important role. Seres Therapeutics is also working to expand its business into other markets. The company has entered into partnerships with leading pharmaceutical companies such as Nestlé and AstraZeneca to explore the potential of microbiome therapy in various indications. Another important initiative of Seres Therapeutics is the exploration of the use of artificial intelligence to identify new microbiome-based therapeutics and improve drug development. Overall, Seres Therapeutics Inc has written a fascinating story by recognizing the potential of the microbiome in combating diseases. The company is on track to become a leading provider of microbiome-based therapeutics and continues its efforts to provide innovative solutions to future medical challenges. Seres Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Seres Therapeutics's Liabilities

Seres Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Seres Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Seres Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Seres Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Seres Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Seres Therapeutics stock

What is the level of liabilities of Seres Therapeutics this year?

Seres Therapeutics has a debt balance of 403.46 M USD this year.

What were the liabilities of Seres Therapeutics compared to the previous year?

The liabilities of Seres Therapeutics have increased by 19.37% increased compared to the previous year.

What are the consequences of high debt for investors of Seres Therapeutics?

High liabilities can pose a risk for investors of Seres Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Seres Therapeutics?

Low liabilities mean that Seres Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Seres Therapeutics affect the company?

An increase in liabilities of Seres Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Seres Therapeutics affect the company?

A decrease in the liabilities of Seres Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Seres Therapeutics?

Some factors that can influence the liabilities of Seres Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Seres Therapeutics so important for investors?

The liabilities of Seres Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Seres Therapeutics take to modify the liabilities?

To change its liabilities, Seres Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Seres Therapeutics pay?

Over the past 12 months, Seres Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Seres Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Seres Therapeutics?

The current dividend yield of Seres Therapeutics is .

When does Seres Therapeutics pay dividends?

Seres Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Seres Therapeutics?

Seres Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Seres Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Seres Therapeutics located?

Seres Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Seres Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Seres Therapeutics from 9/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Seres Therapeutics pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Seres Therapeutics in the year 2023?

In the year 2023, Seres Therapeutics distributed 0 USD as dividends.

In which currency does Seres Therapeutics pay out the dividend?

The dividends of Seres Therapeutics are distributed in USD.